Literature DB >> 17440630

Histidine-lysine peptides as carriers of nucleic acids.

Qixin Leng1, Lisa Goldgeier, Jingsong Zhu, Patricia Cambell, Nicholas Ambulos, A James Mixson.   

Abstract

With their biodegradability and diversity of permutations, peptides have significant potential as carriers of nucleic acids. This review will focus on the sequence and branching patterns of peptide carriers composed primarily of histidines and lysines. While lysines within peptides are important for binding to the negatively charged phosphates, histidines are critical for endosomal lysis enabling nucleic acids to reach the cytosol. Histidine-lysine (HK) polymers by either covalent or ionic bonds with liposomes augment transfection compared to liposome carriers alone. More recently, we have examined peptides as sole carriers of nucleic acids because of their intrinsic advantages compared to the bipartite HK/liposome carriers. With a protocol change and addition of a histidine-rich tail, HK peptides as sole carriers were more effective than liposomes alone in several cell lines. While four-branched polymers with a primary repeating sequence pattern of -HHK- were more effective as carriers of plasmids, eight-branched polymers with a sequence pattern of -HHHK- were more effective as carriers of siRNA. Compared to polyethylenimine, HK carriers of siRNA and plasmids had reduced toxicity. When injected intravenously, HK polymers in complex with plasmids encoding antiangiogenic proteins significantly decreased tumor growth. Furthermore, modification of HK polymers with polyethylene glycol and vascular-specific ligands increased specificity of the polyplex to the tumor by more than 40-fold. Together with further development and insight on the structure of HK polyplexes, HK peptides may prove to be useful as carriers of different forms of nucleic acids both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440630     DOI: 10.1358/dnp.2007.20.2.1083026

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  9 in total

1.  Evaluation of the effect of vector architecture on DNA condensation and gene transfer efficiency.

Authors:  Brenda F Canine; Yuhua Wang; Arash Hatefi
Journal:  J Control Release       Date:  2008-04-23       Impact factor: 9.776

Review 2.  RNAi and small interfering RNAs in human disease therapeutic applications.

Authors:  Monica R Lares; John J Rossi; Dominique L Ouellet
Journal:  Trends Biotechnol       Date:  2010-09-15       Impact factor: 19.536

3.  Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.

Authors:  Q Leng; P Scaria; P Lu; M C Woodle; A J Mixson
Journal:  Cancer Gene Ther       Date:  2008-05-16       Impact factor: 5.987

4.  Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.

Authors:  Renjith P Johnson; Chung-Wook Chung; Young-Il Jeong; Dae Hwan Kang; Hongsuk Suh; Il Kim
Journal:  Int J Nanomedicine       Date:  2012-05-17

5.  A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery.

Authors:  Pilju Youn; Yizhe Chen; Darin Y Furgeson
Journal:  Mol Pharm       Date:  2014-01-16       Impact factor: 4.939

6.  Imaging of the Entry Pathway of a Cell-Penetrating Peptide-DNA Complex From the Extracellular Space to Chloroplast Nucleoids Across Multiple Membranes in Arabidopsis Leaves.

Authors:  Kazusato Oikawa; Ayaka Tateishi; Masaki Odahara; Yutaka Kodama; Keiji Numata
Journal:  Front Plant Sci       Date:  2021-12-03       Impact factor: 5.753

Review 7.  Tinker, Tailor, Tumour Suppressor: The Many Functions of PRP4K.

Authors:  Elias B Habib; Sabateeshan Mathavarajah; Graham Dellaire
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

8.  Establishment of a positive-readout reporter system for siRNAs.

Authors:  Wei-Li Liu; Douglas P Owen; Kerry D Fisher; Leonard W Seymour; Mark Stevenson
Journal:  J RNAi Gene Silencing       Date:  2009-06-12

Review 9.  Solid-phase supported design of carriers for therapeutic nucleic acid delivery.

Authors:  Ana Krhac Levacic; Stephan Morys; Ernst Wagner
Journal:  Biosci Rep       Date:  2017-10-31       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.